Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

MPM Capital (Group)

MPM Capital is an early-stage life sciences venture firm founding and investing in companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. MPM’s portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and more. With its experienced and dedicated team of operating executives and medical and scientific advisory board, MPM is powering novel medical breakthroughs that transform patients’ lives. MPM is currently investing from two funds - the BV2014 and UBS Oncology Impact Fund. *

 

Period Start 2001-07-30 existent
Product Industry venture capital
Persons Person Cagnoni, Pablo J. (MPM Capital 2015– Managing Director + Tizona Therapeutics + Blade Therapeutics before OSI Pharma)
  Person 2 Evnin, Luke (MPM Capital 201307 Managing Director)
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 450 Kendall Street
  City 02142 Cambridge, MA
  Tel +1-617-425-9200
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Harpoon Therapeutics, Inc.. (5/25/17). "Press Release: Harpoon Therapeutics Announces Completion of $45M Series B Financing". South San Francisco, CA.
     
   
Record changed: 2021-06-26

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for MPM Capital (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Lee Hood Speaking 650x300px




» top